12 Health Care Stocks Moving In Thursday’s After-Market Session
Gainers TRACON Pharma (NASDAQ:TCON) stock increased by 71.3% to $0.27 during Thursday’s after-market session. This security traded at…
Earnings Scheduled For November 9, 2023
Companies Reporting Before The Bell
• Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million.
Earnings Outlook For Cano Health
Cano Health (NYSE:CANO) is set to give its latest quarterly earnings report on Thursday, 2023-11-09. Here’s what investors…
Cano Health Announces Consummation Of Previously-Announced 1-For-100 Reverse Stock Split
Cano Health, Inc. ("Cano Health" or the "Company") (NYSE: CANO) today announced that it completed a 1-for-100 reverse stock split of its shares Class A common stock and Class B common stock, including both issued
12 Health Care Stocks Moving In Thursday’s Intraday Session
Gainers ABVC BioPharma (NASDAQ:ABVC) shares moved upwards by 168.2% to $2.28 during Thursday’s regular session. As of 13:31…
12 Health Care Stocks Moving In Friday’s Intraday Session
Gainers Vaccinex (NASDAQ:VCNX) shares rose 26.8% to $1.04 during Friday’s regular session. As of 13:30 EST, Vaccinex’s stock…
Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session
Gainers
Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares jumped 318.5% to $18.54 after the company released top-line results from randomized withdrawal period of study C602 of DCCR for Prader-Willi Syndrome.
Cano Health Sells Substantially All Of Its Primary Care Centers In Texas And Nevada To Centerwell Senior Primary Care; Transaction ~$66.7M, Consisting Of ~$35.4M In Cash Paid At Closing And Release Of Certain Liabilities Owed
Cano Health, Inc. ("Cano Health") (NYSE: CANO) today announced that it sold substantially all of the assets associated with the operation of Cano Health's senior-focused primary care centers in Texas and Nevada to CenterWell Senior Primary Care ("CenterWell").
12 Health Care Stocks Moving In Monday’s Intraday Session
Gainers TransCode Therapeutics (NASDAQ:RNAZ) shares rose 219.3% to $2.12 during Monday’s regular session. TransCode Therapeutics’s stock is trading…